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Abstract
Introduction: As a user-controlled HIV prevention method, oral pre-exposure prophylaxis (PrEP) holds particular promise for
adolescent girls and young women (AGYW). HIV prevention cascades, critical frameworks for the design and evaluation of
PrEP programmes, outline the priorities of identifying individuals at greatest HIV risk and motivating them to initiate PrEP
through perceived HIV risk. To inform future iterations of these cascades and PrEP delivery for AGYW, the objective of this
study was to understand the level of interest in PrEP among AGYW at highest HIV risk, and the potential role of perceived
risk in motivating PrEP interest.
Methods: Using data from a cohort study of HIV-negative AGYW in Lilongwe, Malawi (February 2016 to August 2017), we
assessed the relationship between epidemiologic HIV risk (risk index developed in a previous analysis) and PrEP interest, and
the extent to which perceived risk explains the relationship between HIV risk and PrEP interest. We further aimed to opera-
tionalize the pre-initiation steps of the HIV prevention cascade in the study population.
Results: In total, 825 AGYW were included in analyses, of which 43% met the criterion for high epidemiologic HIV risk. While
epidemiologic risk scores were positively associated with PrEP interest, high numbers of AGYW both above and below the
high-risk cutoff were very interested in PrEP (68% vs. 63%). Perceived risk partially explained the relationship between HIV
risk and PrEP interest; greater epidemiologic HIV risk was associated with high perceived risk, which was in turn associated
with PrEP interest. Many more high-risk AGYW were interested in PrEP (68%) than expressed a high level of perceived HIV
risk (26%).
Conclusions: These results highlight key relationships between epidemiologic HIV risk, risk perception and interest in PrEP.
While risk perception did partially explain the relationship between epidemiologic risk and PrEP interest, there may be other
important motivational mechanisms that are not captured in many HIV prevention cascades. The high number of participants
with risk scores below the high-risk cutoff who both expressed high perceived risk and interest in PrEP suggests that demand
for PrEP among AGYW may not be well aligned with epidemiologic risk.
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1 | INTRODUCTION
Adolescent girls and young women (AGYW) in sub-Saharan
Africa are an important population for HIV prevention [1,2]. In
Malawi, AGYW ages 15 to 24 have more than twice the risk
of HIV infection as their male counterparts [3-5]. This dispro-
portionate burden of HIV risk among AGYW can be explained
by a number of biological, social and behavioural factors [6],
including difficulty negotiating condom use [7,8]. To date, the
predominant prevention technology available in Malawi has
been the male condom, which is primarily male-controlled and
affords women limited ability to protect their sexual health. In
contrast, oral pre-exposure prophylaxis (PrEP) is an effective
individually-controlled prevention method, a promising alterna-
tive or additional prevention tool for AGYW [9-11].
Following World Health Organization (WHO) guidelines rec-
ommending offering PrEP to at-risk populations, including
AGYW in high burden settings [12], many countries including
Malawi are beginning to make provisions to offer PrEP to
AGYW. Despite the promise of PrEP and its impending rollout,
we know little about the acceptability and potential uptake of
PrEP among AGYW, including those in greatest need. With
limited resources for PrEP [13], we need to understand if
those AGYW at greatest HIV risk are the most likely to initi-
ate PrEP. Furthermore, we need to understand how AGYW at
greatest risk may become motivated to consider PrEP.
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HIV prevention cascades provide valuable frameworks and
metrics by which to evaluate the impact of prevention pro-
grammes, and to identify important intermediary endpoints to
guide the development of effective prevention programmes
[14]. The majority of these cascades begin by identifying the
at-risk population [14-17], but the intermediary steps between
identification of this population and initiation of a prevention
method differ across cascades. That said, the thematic com-
monality between intermediary steps in many cascades are
explicit or implicit mechanisms motivating initiation of a given
prevention method. While Schaefer et al.’s 2019 unified cas-
cade is the only to explicitly include a “motivation” step [14],
and Hargreaves et al. similarly include “demand side” factors
which may motivate or facilitate interest and access [18], the
most commonly included motivational step is perceived HIV
risk [15-16,18,19]. The inclusion of risk perception in the
majority of cascades implies that HIV risk perception is a key
process through which individuals at elevated risk may be
motivated to consider PrEP or other HIV prevention methods.
However, empirical data on this implicit assumption are lack-
ing. Understanding whether or not this mechanism is evident
in AGYW can inform whether risk perception is an important
target in programmes to promote PrEP interest and eventual
uptake among high-risk young women, and can be used to
inform future iterations of the HIV prevention cascade to clar-
ify priorities for motivational mechanisms to target.
To address this gap, using data from an observational
cohort study with AGYW in Lilongwe, Malawi we aim to
answer two primary questions: (1) Are those AGYW at high-
est HIV risk actually the most likely to (a) perceive themselves
to be at risk and (b) express interest in PrEP use? and (2) To
what extent does perceived risk explain the relationship
between HIV risk and PrEP interest? We further aim to oper-
ationalize the pre-initiation stages of the prevention cascade
in the study population. The answers to these questions will
build understanding of likely outcomes for key precursors to
PrEP interest and uptake in the early days of rollout to
AGYW.
2 | METHODS
2.1 | Study context
The Girl Power-Malawi study was conducted at four health
centres in Lilongwe, Malawi from February 2016 to August
2017 and assessed four service delivery models for AGYW
[20,21]. All clinics were in urban and periurban areas and
had antenatal HIV prevalence levels of at least 5%. None of
the models of service delivery included PrEP information or
PrEP services. At the one-year follow-up participants were
asked about their hypothetical interest in PrEP. The data pre-
sented here are taken from behavioural surveys from this
trial.
2.2 | Study participants and procedures
Two-hundred and fifty AGYW were recruited from the catch-
ment areas surrounding each of the four study clinics
(n = 1000 total) through community outreach, participant
referral, and self-referral. AGYW were eligible to participate if
they were 15 to 24 years old, from the catchment area, and
willing to provide locator information (phone number and/or
physical location). AGYW who were sexually active in the past
six months were purposively recruited; study staff informally
discussed romantic relationships and sexual activity with
AGYW and invited those with current or past sexual activity
for screening. Eligible and consenting participants were
enrolled and followed for one year. All participants were asked
to complete a behavioural survey at baseline, six months, and
one year assessing socioeconomic, behavioural, biomedical and
partnership characteristics; interest in using PrEP; and HIV
risk perception. Surveys were administered in Chichewa by
young female research officers using Open Data Kit software
[22]. Phone and physical tracing were conducted for partici-
pants who missed research visits. Eight-hundred and sixty-
seven AGYW participated in the one-year visit (87% reten-
tion). The present analysis excludes AGYW who reported an
HIV-positive test result by the one-year follow-up visit (42
participants).
2.3 | Ethical review
Girl Power-Malawi received approval from the National
Health Science Research Committee in Malawi and the
University of North Carolina Institutional Review Board. Vol-
untary written informed consent was obtained from partici-
pants 18 to 24 years old. Assent and permission by a parent,
guardian or authorized representative were obtained for ado-
lescents 15 to 17 years old. In cases of limited literacy, an
impartial witness was present.
2.4 | Measures
2.4.1 | Epidemiologic HIV risk
Indicators of HIV risk used were previously identified as those
associated with HIV incidence in the Girl Power-Malawi
cohort [23]. All nine identified risk factors were assessed at
one year. Indicators included two sociodemographic factors
(age 20 to 24; being separated/divorced/widowed), four sexual
partnership characteristics in the past six months (≥2 part-
ners; exchanging sex for money or gifts (transactional sex);
having ≥1 partner ≥5 years older; and known/suspected part-
ner concurrency), two sexually transmitted infections (STI)
symptoms in the past six months (abnormal vaginal discharge;
genital sores/ulcers) and having a previous pregnancy (mea-
sures previously described [24]). In our previous work to
develop this risk index, AGYW with ≥3 risk factors were 15.2
times as likely to acquire HIV as those with <3 factors [23].
We summed the nine risk indicators by participant to create a
risk score, and created a dichotomous of “high risk” indicator
for some analyses (≥3 factors indicating “high risk”). This high-
risk cutoff was determined in the previous analysis; those with
≥3 risk factors had an HIV incidence rate >3 per 100 person-
years, the WHO high-risk threshold [25].
2.4.2 | Perceived HIV risk
AGYW rated their perceived lifetime chance of acquiring HIV
as: “no chance,” “small chance” or “high chance.” In bivariate
analyses, this was dichotomized as “high chance” (1) versus
other responses (0).
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2.4.3 | PrEP interest
AGYW were rated their potential interest in using PrEP after
receiving this explanation: “PrEP is a medicine that can be
used to prevent HIV for people who are HIV-negative. To be
protected with PrEP, a pill is taken every day. These pills con-
tain some of the same medicine used to treat people who
already have HIV. PrEP is not currently available in Malawi.”
Participants rated their interest in trying PrEP if it were avail-
able at the study clinic (“not at all interested,” “somewhat
interested” or “very interested”). For multivariate analyses, this
was dichotomized as “very interested” (1) versus other
responses (0).
Control variables included highest level of education (grade
level) and household economic status evaluated through an
adapted Filmer Pritchett Wealth Index including 13 household
assets [26]. A composite wealth score was created by weighting
each asset by its factor loading on the first component in a prin-
ciple components analysis, placing individuals on a continuous
scale of relative wealth and categorizing scores into terciles [26].
2.5 | Analysis
All analyses were performed in SAS v 9.4. We tested the follow-
ing hypotheses: (1) Women with greater HIV risk will be more
likely to a) be very interested in PrEP and b) perceive high HIV
risk; (2) Women with greater perceived risk will be more likely to
be very interested in PrEP; (3) Perceived risk will mediate the
relationship between HIV risk and PrEP interest per hypotheses
1&2.We described the frequencies and percentages of categori-
cal variables, and the median and inter-quartile range of continu-
ous variables (Table 1). We then estimated unadjusted and
adjusted odds ratios of the association between each exposure
and outcome of interest and corresponding 95% Wald chi-
square confidence intervals (Table 2). As adjustment for the con-
trol variables above did not qualitatively alter the results, only
adjusted odds ratios are presented. To assess the assumption of
linear associations between epidemiologic HIV risk and the
response variables, we compared the fit of the linear model with
three alternatives: a quadratic, a cubic, and a categorical model.
Likelihood ratio tests did not indicate improved fit with these
alternative models [27].
We assessed the mediation hypothesis by estimating indirect
and direct effects using the PROCESS macro v3.3 [28]. Statistical
mediation was determined by assessing the statistical signifi-
cance of the indirect effect (product of a*b; Figure 1) by the cri-
terion of a non-zero bootstrapped 95% confidence interval
(5000 resamples) [28,29]. Estimates for each path are adjusted
for the control variables above; in this analysis we assume no
unmeasured confounding for the causal effect of the mediator on
the outcome. The proportion of the relationship between HIV
risk and PrEP interest explained by the perceived risk mediator
was calculated as 1-c’/c (Figure 1) [28]. Finally, to characterize
the “cascade” of level of perceived HIV risk and PrEP interest
among high HIV risk AGYW, we calculated conditional frequen-
cies of high perceived risk and being very interested in PrEP in
this group (Figure 2). All hypothesis tests were completed using
an imputed dataset. Given low levels of missing information (6%
or less per variable), we employed deterministic imputation as
follows [30]: Deterministic regression imputation for variables
missing for >2% of participants; median imputation for variables
missing for <2% of participants. PrEP, pre-exposure prophylaxis;
STI, sexually transmitted infections.
3 | RESULTS
3.1 | Participant characteristics
In total, 825 AGYW completing the one-year assessment not
reporting an HIV-positive test result were included. At one
year, the median age of participants was 20 years old
(Table 1). Half had completed primary school (51%) and a
Table 1. Descriptive Statistics at one year (N = 825)
n (%) or median [IQR]
Age 20 [18 to 22] (range: 15
to 27)
Highest education level completed
Less than a primary school education 179 (21.8%)
Primary school completed (8 to 11) 417 (50.9%)
Secondary school completed 244 (27.3%)









Sexually active in past six months 796 (96.5%)
PrEP interest
Not all interested 99 (12.7%)
Somewhat interested 168 (21.5%)
Very interested 515 (65.9%)
Perceived lifetime HIV risk
No chance 504 (61.1%)
Small chance 122 (14.8%)
High chance 149 (18.1%)
Do not know 49 (5.9%)
HIV risk
Risk count score
Risk factor count 2 [1 to 3] (range: 0 to 8)
High risk (≥3 risk factors of 9) 351 (42.6%)
Risk factors
Age 20+ 491 (56.6%)
Separated, divorced, or widowed 55 (6.7%)
≥2 partners in past year 178 (22.4%)
STI symptoms (past six months)
Ulcerative symptoms 55 (6.7%)
Discharge symptoms 72 (8.8%)
Transactional sex 162 (18.8%)
≥1 partner suspected concurrent 390 (47.3%)
≥1 partner ≥5 years older than
participant
227 (29.4%)
Ever pregnant 357 (43.3%)
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quarter (27%) had completed secondary school. The majority
of participants (66%) were single. Nearly all participants
reported being sexually active in the past six months (97%).
The median number of HIV risk factors reported was 2.
43% met the “high-risk” cutoff of ≥3 risk factors. Most partici-
pants (61%) perceived no lifetime risk of HIV infection, while
15% and 18% perceived a small or high risk respectively. The
majority (66%) were very interested in PrEP while 22% were
somewhat interested, and 13% reported no interest.
3.2 | Epidemiologic HIV risk and PrEP interest
The number of reported risk factors was associated with PrEP
interest (Table 2); each additional risk factor was associated
Table 2. Associations between HIV risk factors, perceived HIV risk, and PrEP interest
Risk factors (ref = first)
PrEP interest (“very”) Perceived “high” HIV risk
n (%)a aOR (95% CI) n (%)a aOR (95% CI)
Perceived HIV risk
No chance 295 (61.8%) – – –
Small chance 83 (69.2%) 1.46 (0.95, 2.24) – –
High chance 111 (78.2%) 2.60 (1.68, 4.04)** – –
Epidemiologic HIV risk
Risk factor count – 1.13 (1.03, 1.24)** – 1.28 (1.15, 1.42)***
Low/moderate risk (<3 risk factors) 297 (63.1%) 1.24 (0.92, 1.68) 58 (12.3%) 2.33 (1.60, 3.38)***
High risk (≥3 risk factors) 238 (67.8%) 91 (25.7%)
HIV risk indicators
Age 15 to 19 246 (74.1%) 0.65 (0.48, 0.89)** 60 (17.8%) 1.37 (0.94, 2.00)
Age 20+ 269 (59.8%) 89 (20.4%)
Not separated, divorced, or widowed 497 (64.6%) 1.24 (0.68, 2.27) 135 (17.5%) 1.32 (0.70, 2.53)
Separated, divorced, or widowed 38 (69.1%) 14 (25.5%)
<2 partners in past year 369 (62.7%) 1.87 (1.27, 2.75)** 104 (17.7%) 1.50 (1.00, 2.27)
≥2 partners in past year 127 (76.1%) 43 (26.5%)
STI symptoms (past six months)
No ulcerative symptoms 475 (65.0%) 1.46 (0.78, 2.75) 136 (18.8%) 1.39 (0.72, 2.70)
Ulcerative symptoms 40 (78.4%) 13 (25.5%)
No discharge symptoms 462 (65.3%) 1.14 (0.67, 1.92) 126 (17.9%) 1.97 (1.13, 3.42)*
Discharge symptoms 49 (71.0%) 21 (31.3%)
No transactional sex 397 (62.7%) 2.24 (1.46, 3.44)** 117 (18.6%) 1.15 (0.73, 1.80)
Transactional sex 115 (78.8%) 32 (22.5%)
No partner suspected concurrent 266 (61.2%) 1.42 (1.06, 1.90)* 49 (11.3%) 2.72 (1.86, 3.98)***
≥1 partner suspected concurrent 269 (69.0%) 100 (25.6%)
No partner ≥5 years older than participant 416 (64.0%) 1.58 (1.13, 2.21)** 122 (18.9%) 1.55 (1.06, 2.27)*
≥1 partner ≥5 years older than participant 94 (77.1%) 26 (21.7%)
Never pregnant 292 (67.4%) 0.99 (0.73, 1.35) 62 (14.1%) 1.73 (1.18, 2.54)**
Ever pregnant 222 (63.8%) 86 (25.8%)
aORs adjusted for household economic status and education; aOR reference group is the first value listed in each row.
a
Row percent reflecting proportion of respondents for each response category reporting being “very” interest in pre-exposure prophylaxis (PrEP)
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with 13% higher odds of being “very” interested in PrEP
(aOR = 1.13; 95% CI: 1.03, 1.24). Slightly more AGYW
reporting ≥3 risk factors (“high risk”) were very interested in
PrEP, but this relationship was not statistically significant
(Table 2). Four of the nine risk factors were associated with
being very interested in PrEP in the expected direction: ≥2
partners, transactional sex, known/suspected partner concur-
rency, ≥1 partner ≥5 years older. Unexpectedly, women
20 years and older had lower odds of PrEP interest than
those younger than 20 years. The other risk factors were not
associated with PrEP interest.
3.3 | Perceived HIV risk and PrEP interest
Both level of perceived risk and reporting “high” perceived
HIV risk were associated with PrEP interest (Table 2). AGYW
reporting high perceived risk had over twice the odds of being
very interested in PrEP (aOR = 2.60; 95% CI: 1.68, 4.04) as
those reporting lower perceived risk. PrEP interest was high
among all perceived risk levels: 62% among women reporting
no perceived risk, 69% among those with low perceived risk,
and 78% among those with high perceived risk.
3.4 | Mediation by perceived HIV risk: Indirect
effect and direct effects
The indirect effect of epidemiologic HIV risk on PrEP interest
through the mediator of perceived HIV risk was significant for
both the binary indicator of high HIV risk and HIV risk score
(Table 3; respective aORs: 1.14 95% CI: 1.05, 1.24; 1.04 95%CI:
1.01, 1.06). Perceived HIV risk explained 19% of the relationship
between high epidemiologic risk and PrEP interest, and 25% of
the relationship between HIV risk score and PrEP interest.
3.5 | Operationalized pre-initiation PrEP cascade
Many more high-risk AGYW were interested in PrEP than
perceived themselves to be at high risk (Figure 2); of the 351
high-risk participants, only 26% perceived high HIV risk, while
68% were very interested in PrEP. Of the 91 high-risk partici-
pants who also had high perceived HIV risk, 78% were very
interested in PrEP (striped bar).
4 | DISCUSSION
In summary, nearly half of AGYW reported risk factors placing
them at high epidemiologic HIV risk. The majority expressed
interest in PrEP, and epidemiologic risk was moderately associ-
ated with this interest. Only 26% of high-risk participants
reported high perceived risk, but nevertheless were more likely
to perceive high risk than their lower-risk counterparts. Per-
ceived risk explained a quarter of the relationship between HIV
risk and PrEP interest, suggesting that there may be other mech-
anisms motivating higher-risk AGYW’s interest in PrEP.
4.1 | HIV risk and PrEP interest
The majority of AGYW were very interested in PrEP, and this
interest was moderately associated with higher HIV risk
scores. Risk indicators most closely associated with PrEP
interest included behavioural and partner factors which
AGYW might recognize from HIV-prevention education (e.g.
partner concurrency, age disparate relationships). Approxi-
mately two-thirds of both high-risk and lower-risk women
were very interested in PrEP. This generally high level of PrEP
interest has been found in other populations of AGYW and
older women in South Africa [31-33] and Kenya [34].
Although these findings represent hypothetical interest, they
suggest that demand for PrEP among AGYW may not be well
aligned with epidemiologic HIV risk. Because of currently lim-
ited resources for PrEP in many settings, demand for PrEP
according to HIV risk should be monitored to assess the need
to better target PrEP delivery to women at greatest risk [35].
4.2 | HIV risk and perceived risk
Although women with higher epidemiologic risk were more
likely to report high perceived risk, 74% of those with high-risk
scores did not have high perceived risk. These results echo
Figure 1. Mediation hypothesis and paths. PrEP, pre-exposure pro-
phylaxis
Figure 2. Operationalized pre-initiation PrEP cascade.
aProportion of high-risk participants (n = 351) reporting being very
interested in PrEP. bProportion of high-risk participants with high per-
ceived HIV risk (n = 91) reporting being very interested in PrEP. PrEP,
pre-exposure prophylaxis
Table 3. Mediation results: indirect, direct and total effects of
HIV risk on PrEP interest via perceived risk
aOR (95% CI)
X = high HIV risk X = HIV risk score
Indirect effect 1.14 (1.05, 1.24) 1.04 (1.01, 1.06)
Direct effect 1.19 (1.05, 1.24) 1.10 (1.00, 1.20)
Total effect 1.24 (0.92, 1.68) 1.13 (1.03, 1.23)
Proportion mediated 19.2% 25.2%
aORs adjusted for household economic status and education. PrEP,
pre-exposure prophylaxis; CI, confidence interval.
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findings from FEM-PrEP that half of women sero-converting
while taking PrEP had reported no perceived chance of HIV
acquisition. This was attributed by the investigators to overes-
timation of protective behaviours and protective reasoning
(e.g. minimizing perceived risk, cognitive avoidance) [36].
4.3 | Perceived risk as a motivating mechanism
The mediation results indicated that perceived risk partially
explained the relationship between epidemiologic risk and
PrEP interest, thus there is reason to infer that perceived risk
may be a motivating mechanism for PrEP interest in higher-
risk women. Future randomized studies should seek to under-
stand if interventions promoting accurate risk perception could
promote PrEP initiation [23]. Yet, perceived risk explained only
a quarter of the relationship between risk scores and PrEP
interest, indicating that there may be other unobserved moti-
vators. Qualitative studies should seek to understand addi-
tional factors motivating AGYW’s PrEP interest beyond
perceived risk. While some cascades include additional poten-
tial motivators, including attitudes towards the prevention
method, social norms [18], and risk/benefit perceptions [19],
more work is needed to understand the primary motivating
mechanisms for PrEP initiation, to identify unified motivation
indicators to inform and evaluate prevention programmes [14].
More research is needed to understand why many women
who perceive no lifetime HIV risk would be very interested in
PrEP. Previous evidence suggests that AGYW’s PrEP decision-
making can be driven by emotion and motivated reasoning
about partner risk [37]. Our qualitative work with the study
population suggests that fear of unplanned or uncontrollable
risk factors including condom use errors, suspected/feared
partner concurrency, and fear of rape were motivators for
PrEP interest [38]. These factors could be seen as sources of
HIV risk yet unlikely or hypothetical and therefore may not
necessarily impute to a high perceived HIV risk while still
serving to motivate interest in PrEP. Building a better under-
standing of these motivations will be important for the devel-
opment and consolidation of PrEP-specific and other HIV
prevention cascades [15-16,19]. Inclusion of cascade indica-
tors reflecting a more robust understanding motivators for
interest in PrEP and other HIV prevention technologies will
encourage activities to target the most important precursors
to PrEP uptake and prevention-effective use [14].
4.4 | The cascade framework and PrEP
Unlike HIV treatment cascades, our operationalized pre-initia-
tion PrEP cascade (Figure 2) was non-linear: many more
AGYW with high risk scores were interested in PrEP than
perceived themselves to be at high risk. There have been simi-
lar findings in men who have sex with men [39,40]. This find-
ing could be partially attributed to the fact that
acknowledging interest in PrEP may present a lower “thresh-
old” with regard to social desirability than acknowledging HIV
risk behaviours or perceptions of HIV risk. This highlights a
potential weakness of the cascade framework in defining pro-
gress towards PrEP initiation in high-risk individuals. While
each bar in an HIV treatment cascade is generally a subset of
the previous one, this may not be the case for PrEP. This
potential characteristic could make setting 90-90-90 type
targets for PrEP difficult, as the denominator for each step
may be difficult to define.
Our results highlight one further question about the applica-
tion of the cascade framework for PrEP. Over 60% of partici-
pants with low/moderate-risk scores were very interest in
PrEP, and 12% of women with these scores reported high per-
ceived risk. Should these women be excluded from the PrEP
“target population” as defined by cascades? Women may be
reticent to report risk behaviours [41,42], or may fear risks
that could not be reported as current, known risk factors, as
those assessed in most common risk indices (as in our qualita-
tive work [38]). Future studies should seek to understand the
potential implications of more expansive definitions of the tar-
get population and PrEP eligibility criteria based on perceived
risk and expressed PrEP interest. This evidence is needed to
inform policy discussions to determine the potential societal
costs and benefits of offering PrEP to those who may be highly
motivated to use it but are not at highest assessable risk.
Future studies should also seek to understand the downstream
effects of HIV risk perception and other potential motivators
of PrEP use on retention in care and adherence, as qualitative
evidence suggests that low perceived risk and insufficient
motivation for PrEP use may be related to the low levels of
adherence among women in PrEP demonstration trials [43-47].
5 | LIMITATIONS
The results of this study should be interpreted with key limi-
tations in mind. First, participants’ reports of PrEP interest,
sexual behaviours and perceptions of risk were likely suscepti-
ble to social desirability bias. To mitigate this issue, partici-
pants were assured that their responses were confidential
and that there were no right or wrong answers. We also used
the highest threshold (“very”) for PrEP interest to increase
the theoretical specificity of this indicator. Second, few partici-
pants had previous knowledge of PrEP and PrEP was not
available in the study setting at measurement, thus their
reported interest in PrEP was hypothetical and based on lim-
ited consideration. Third, perceived HIV risk was measured
with a single item, and thus may not capture all dimensions of
perceived risk. Fourth, due to low cell counts for the associa-
tions between STI symptoms and PrEP interest, and between
being separated/divorced/widowed and PrEP interest, tests
may have been underpowered. Fifth, causal interpretations of
all measures of association presented should be made with
caution as they represent cross-sectional associations; qualita-
tive studies are needed to better understand the causality of
the relationships studied. Finally, sexually active AGYW were
purposively recruited for participation from urban and periur-
ban settings in Lilongwe. The findings of this study are primar-
ily generalizeable to sexually active AGYW living in similar
urban and periurban settings in the region.
6 | CONCLUSIONS
Our results bring to light relationships between epidemiologic
risk, risk perception and PrEP interest and indicate directions
for future research to inform effective HIV prevention pro-
grammes. A better understanding of mechanisms motivating
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PrEP interest beyond perceived risk is needed to inform deliv-
ery of PrEP among AGYW in high burden settings. Our results
suggest that early demand for PrEP may not be well aligned
with epidemiologic risk in this population; more research is
needed to understand the implications of expanding or retain-
ing current target population and PrEP eligibility definitions
which may exclude many interested and motivated potential
users not meeting a cutoff for epidemiologic risk.
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